MELANIE MENDOZA-AGUILAR: Open Payments
NPI 1750065769 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$494 in 17 payments from 5 companies in 2025. Trend: 2023 $302 · 2024 $344 · 2025 $494
Food & beverage: $494
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $172 |
| Alnylam Pharmaceuticals Inc. | 5 | $157 |
| Edwards Lifesciences Corporation | 2 | $104 |
| PFIZER INC. | 1 | $38 |
| BridgeBio Pharma, Inc. | 1 | $23 |
Products named: JARDIANCE, AMVUTTRA, SAPIEN 3 Ultra RESILIA, ELIQUIS, Attruby.
Industry payments across NY — which companies pay providers there.
